The biotech is now banking on secondary data signals as it progresses ignaseclant to late-stage trials in Charcot-Marie-Tooth ...

The Wolverhampton mum shared how her daughter's diagnosis was "too much to take in" ...

A hardworking father-of-three has revealed the warning sign that he had developed motor neurone disease at the age of just 39 ...

A dad-of-three has been diagnosed with motor neurone disease aged just 39 – after losing grip in his left hand. Ryan Horsfall ...

She slept in hospital intensive care units and navigated family outings with a breathing machine – all for her late son, who ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has missed its primary endpoint. | A phase 2a trial of NMD ...

Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and ...

A father-of-three has received a motor neurone disease diagnosis at just 39 years old after experiencing a loss of grip in ...

After witnessing my father’s tortuous battle with the illness I wanted to understand my own risk, so I visited a brain expert ...

Ryan Horsfall was at work when he realised he couldn't pick anything up ...